Sourcing high-purity Bronchogen for sale requires rigorous verification of peptide identity, sequence integrity, and mass purity. PX1 Research supplies research-grade Bronchogen (Ala-Asp-Glu-Leu) manufactured in USA-based facilities, verified via RP-HPLC and ESI-MS, and delivered with lot-specific certificates of analysis strictly for in vitro and preclinical research applications.
Sourcing high-purity Bronchogen for sale requires rigorous verification of peptide identity, sequence integrity, and mass purity. PX1 Research supplies research-grade Bronchogen (Ala-Asp-Glu-Leu) manufactured in USA-based facilities, verified via RP-HPLC and ESI-MS, and delivered with lot-specific certificates of analysis strictly for in vitro and preclinical research applications.
When purchasing synthetic peptides for rigorous biochemical analysis, acquiring highly purified reference material is paramount. Bronchogen is a synthetic short-chain peptide bioregulator comprised of four amino acid residues: L-alanyl-L-alpha-aspartyl-L-alpha-glutamyl-L-leucine (Ala-Asp-Glu-Leu). Researchers investigating respiratory tissue culture models, epigenetics, cellular senescence, and gene expression modulation require consistent chemical specifications from lot to lot.
Investigators exploring bronchogen for sale within academic or institutional settings must ensure that incoming reagents meet strict analytical parameters. PX1 Research delivers laboratory-grade peptides synthesized in state-of-the-art facilities compliant with GMP frameworks. Every batch undergoes exhaustive analytical testing—including high-performance liquid chromatography and mass spectrometry—to confirm that raw sequences match theoretical molecular weights without sequence truncation or residual impurities.
Bronchogen belongs to the peptide bioregulator class—a family of short-chain oligopeptides designed to interact directly with nucleosomal DNA and histones. With a molecular formula of C18H30N4O9 and a theoretical molecular weight of approximately 446.45 g/mol, this tetrapeptide features polar acidic residues (aspartic acid and glutamic acid) coupled with alanine and leucine.
In structural biology literature, short regulatory peptides are documented to penetrate cellular and nuclear membranes without requiring active transport systems. The specific charge distribution across the Ala-Asp-Glu-Leu sequence allows for targeted binding interactions within the minor groove of double-stranded DNA. Scientists evaluating candidates across our complete research peptide catalog often examine how sequence modifications influence DNA-binding affinity and promoter region accessibility.
Preclinical evidence indicates that short peptide bioregulators act primarily through epigenetic mechanisms. In cell-free and cellular assays, Bronchogen has demonstrated an ability to induce site-specific DNA demethylation and chromatin unwinding. By destabilizing heterochromatin structures, the peptide enhances RNA polymerase accessibility to gene promoter regions controlling cellular homeostasis and repair pathways.
In vitro models utilizing bronchial epithelial cells suggest that Bronchogen exposure modulates the transcription of key structural proteins, antioxidant enzymes, and cell-surface markers. Research published in molecular biology journals reveals that short peptides like Ala-Asp-Glu-Leu can re-reactivate silenced genes in senescent cell lines, providing a robust experimental framework for exploring pulmonary tissue regeneration and cellular longevity. To review foundational concepts surrounding short peptide mechanisms, researchers can explore our dedicated peptide bioregulators research guide.
In vivo rodent models evaluating pulmonary stress and toxic lung injury have provided valuable data regarding Bronchogen's functional effects. Animal studies involving acute respiratory distress or chemical toxicity demonstrated that administration of short synthetic peptides reduced inflammatory biomarker expression, attenuated pulmonary fibrosis markers, and preserved alveolar architecture compared to untreated control groups.
Furthermore, explant cultures derived from mammalian lung tissue showed accelerated epithelial cell proliferation and enhanced surfactant protein production following exposure to short regulatory sequences. While these preclinical findings highlight significant biological activity in controlled laboratory settings, Bronchogen remains strictly an investigational tool. It is supplied exclusively for in vitro diagnostic assays, structural modeling, and animal research—never for human or clinical use.
Sourcing reliable research chemicals requires strict adherence to analytical validation standards. When evaluating options to acquire research peptides, laboratories must demand comprehensive analytical documentation for every lot. Impurities such as unreacted peptide fragments, trifluoroacetate (TFA) salts, heavy metals, or bacterial endotoxins can invalidate experimental outcomes and skew assay data.
At PX1 Research, quality assurance is embedded into every step of the manufacturing and distribution protocol. Every batch of Bronchogen is subjected to a dual-tier verification process in an independent ISO 17025 accredited laboratory. Researchers receive a full Certificate of Analysis (COA) containing detailed analytical chromatograms and mass spectra.
To guarantee chemical purity exceeding 98%, PX1 Research utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). RP-HPLC separates the target sequence from synthesis side-products based on hydrophobicity, ensuring single-peak resolution and accurate quantification of chemical purity.
Electrospray Ionization Mass Spectrometry (ESI-MS) is conducted simultaneously to verify exact molecular mass, ruling out deletion sequences or improper amino acid coupling. Furthermore, because bacterial endotoxins can provoke non-specific inflammatory signaling in cell culture models, PX1 Research tests every batch using Limulus Amebocyte Lysate (LAL) assays to confirm endotoxin levels fall below <0.5 EU/mg. Principal investigators seeking large quantities for high-throughput screening can utilize our bulk research accounts program to establish batch-locked inventory.
Within short-chain bioregulator research, Bronchogen is frequently analyzed alongside other synthetic peptide sequences targeting specific organ systems. Comparative studies assess sequence-specific DNA binding affinities, thermal stability, and tissue-specific promoter reactivation across different cell lineages.
For instance, while Bronchogen (Ala-Asp-Glu-Leu) is primarily evaluated in bronchial and pulmonary epithelial models, Vilon (Lys-Glu) is studied for its broader immunomodulatory and chromatin-activating effects across immune cell lineages. Similarly, Epitalon (Ala-Glu-Asp-Gly) is investigated for telomerase activation and pineal gland gene modulation, whereas Cartalax (Ala-Glu-Asp) targets extracellular matrix production in chondrocytes. Researchers interested in tissue-repair signaling pathways also evaluate general cytoprotectants like BPC-157 alongside bioregulators in comparative preclinical assays. Detailed comparative datasets can be found across our comprehensive peptide research library.
Bronchogen is supplied as a lyophilized (freeze-dried) powder to maintain maximum chemical stability during transit and storage. Upon receipt, lyophilized vials should be stored at -20°C or -80°C in a desiccated environment protected from light. Under these conditions, the peptide remains stable for up to 24 months without significant degradation.
For laboratory reconstitution, researchers should handle vials under a laminar flow hood using sterile, research-grade solvents such as Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline (PBS, pH 7.4). After adding solvent along the internal glass wall of the vial, gently swirl the container—avoid violent vortexing or shaking, which can cause mechanical shear stress or aggregation. For detailed volume calculations, researchers can reference our peptide reconstitution tool. Reconstituted solutions should be aliquoted into single-use microcentrifuge tubes and stored at -20°C to prevent freeze-thaw degradation cycles.
PX1 Research is an established USA-based supplier dedicated exclusively to supporting academic, biotechnology, and institutional research programs. We understand that experimental reproducibility depends entirely on reagent purity and transparent sourcing. By maintaining domestic synthesis facilities and rigorous ISO 17025 testing protocols, we eliminate supply chain uncertainties.
Orders placed before cut-off times ship same-day from our dual fulfillment centers in California and Arizona, utilizing temperature-monitored packaging to safeguard compound integrity. Whether your project requires individual analytical vials or custom scale synthesis, PX1 Research delivers verified compounds backed by lot-traceable documentation.
What is Bronchogen, and what is its primary sequence?
Bronchogen is a synthetic short-chain peptide bioregulator composed of four amino acids: L-alanyl-L-alpha-aspartyl-L-alpha-glutamyl-L-leucine (Ala-Asp-Glu-Leu). It is studied in preclinical research for its interactions with DNA and chromatin remodeling.
Is Bronchogen supplied by PX1 Research intended for human consumption?
No. All products sold by PX1 Research, including Bronchogen, are strictly for laboratory research, in vitro diagnostic assays, and preclinical animal investigation. They are never for human, clinical, or therapeutic use.
How does PX1 Research verify the purity of Bronchogen?
Every lot of Bronchogen undergoes rigorous analytical testing in an ISO 17025 accredited laboratory using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity assessment and Electrospray Ionization Mass Spectrometry (ESI-MS) for sequence identification.
What endotoxin levels are acceptable for research-grade Bronchogen?
PX1 Research conducts Limulus Amebocyte Lysate (LAL) testing on every batch to ensure endotoxin levels remain below <0.5 EU/mg, protecting delicate cell culture models from endotoxin-induced background noise.
What solvent should be used for reconstituting lyophilized Bronchogen?
Bronchogen readily dissolves in sterile laboratory solvents such as Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline (PBS, pH 7.4). The choice of solvent depends on the specific requirements of your downstream assay.
How should reconstituted Bronchogen solutions be stored?
Once reconstituted, Bronchogen should be divided into single-use aliquots to avoid repeated freeze-thaw cycles and stored at -20°C or -80°C. Aliquots kept at 4°C should be utilized within 7 to 14 days.
Where does PX1 Research ship products from?
PX1 Research synthesizes and packages peptides in USA-based facilities. Orders are fulfilled and shipped directly from our primary distribution hubs located in California and Arizona, offering same-day shipping on orders placed Monday through Friday.
How can I obtain a copy of the Certificate of Analysis (COA) for my order?
A lot-specific COA containing complete HPLC chromatograms and mass spectrometry reports is available for download on the PX1 Research platform or provided directly with your order shipment upon request.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.